In vitro analysis of neurospheres derived from glioblastoma primary culture: A novel methodology paradigm

Frontiers in Neurology

Volumn 4 JAN, Issue , 2014, Pages

  Pavon, Lorena Favaro ^a,b   Marti, Luciana C ^b,c   Sibov, Tatiana Tais ^a,b   Malheiros, Suzana M F ^a,b   Brandt, Reynaldo Andre ^b   Cavalheiro, Sergio ^a   Gamarra, Lionel F ^a,b,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

Author keywords

Adherent stem cell; CD133; Glioblastoma; Methods; Neurosphere subspheres; Primary culture

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; HERMES ANTIGEN; NESTIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; BRAIN CELL CULTURE; CELL FRACTIONATION; CELL ISOLATION; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NEUROSPHERE; PROTEIN EXPRESSION;

EID: 84893476711     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00214     Document Type: Article

References (37)

1. Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G, Vecht C, et al. Glioblastoma in adults. Crit Rev Oncol Hematol (2008) 67:139-52. doi: 10.1016/j.critrevonc.2008.02.005.
2. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med (2008) 359:492-7. doi:10.1056/NEJMra0708126.
3. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 63(18):5821-8.
4. Setoguchi T, Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines. Cell Cycle (2004) 3:414-5. doi:10.4161/cc.3.4.795.
5. Uchida H, Arita K, Yunoue S, Yonezawa H, Shinsato Y, Kawano H, et al. Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells. J Neurooncol (2011) 4(3):694-7. doi:10.1007/s11060-011-0552-2.
6. Wang J, Sakariassen Pø, Tsinkalovsky O, Immervoll H, Bøe SO, Svendsen A, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer (2008) 122(4):761-8. doi:10.1002/ijc.23130.
7. Son MJ, Woolard K, Nam DH, Lee J, Fine HA. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell (2009) 4(5):440-52. doi:10.1016/j.stem.2009.03.003.
8. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res (2008) 14(1):123-9. doi:10.1158/1078-0432.CCR-07-0932.
9. Facchino S, Abdouh M, Chatoo W, Bernier G. BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci (2010) 28(30):1096-111. doi:10.1523/JNEUROSCI.1634-10.2010.
10. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De VitisS, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res (2004) 64(19):7011-21. doi:10.1158/0008-5472.CAN-04-1364.
11. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133+ and CD133-glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 67:4010-5. doi:10.1158/0008-5472.CAN-06-4180.
12. Dell'Albani P. Stem cell markers in gliomas. Neurochem Res (2008) 33(12):2407-15. doi:10.1007/s11064-008-9723-8.
13. Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene (2008) 27(20):2897-909. doi:10.1038/sj.onc.1210949.
14. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, MacSwords J, et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell (2010) 6(5):421-32. doi:10.1016/j.stem.2010.02.018.
15. Pollard SM, Conti L, Sun Y, Goffredo D, Smith A. Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex (2006) 16(1):112-20. doi:10.1093/cercor/bhj167.
16. Morrison CD, Prayson RA. Immunohistochemistry in the diagnosis of neoplasms of the central nervous system. Semin Diagn Pathol (2000) 17(3):204-15.
17. Lenkiewicz M, Li N, Singh SK. Culture and isolation of brain tumor initiating cells. Curr Protoc Stem Cell Biol (2009) 3:3.3. doi:10.1002/9780470151808.sc0303s11.
18. Pavon LF, Marti LC, Sibov TT, Malheiros SM, Oliveira DM, Guilhen DD, et al. The ultrastructural study of tumorigenic cells using nanobiomarkers. Cancer Biother Radiopharm (2010) 25(3):289-98. doi:10.1089/cbr.2009.0697.
19. Cho DY, Lin SZ, Yang WK, Hsu DM, Lin HL, Lee HC, et al. The role of cancer stem cells (CD133+) in malignant gliomas. Cell Transplant (2011) 5:121-5. doi:10.3727/096368910X532774.
20. Natsume A, Kinjo S, Yuki K, Kato T, Ohno M, Motomura K, et al. Glioma-initiating cells and molecular pathology: implications for therapy. Brain Tumor Pathol (2011) 28:11-2. doi:10.1007/s10014-010-0011-3.
21. Sato A, Sakurada K, Kumabe T, Sasajima T, Beppu T, Asano K, et al. Brain Tumor Study Group. Association of stem cell marker CD133 expression with dissemination of glioblastomas. Neurosurg Rev (2010) 33(2):175-83. doi:10.1007/s10143-010-0239-8.
22. Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, et al. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer (2011) 117(1):162-74. doi:10.1002/cncr.25581.
23. Tamase A, Muraguchi T, Naka K, Tanaka S, Kinoshita M, Hoshii T, et al. Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc Natl Acad Sci USA (2009) 106(40):17163-8. doi:10.1073/pnas.0905016106.
24. Cheng JX, Liu BL, Zhang X. How powerful is CD133 as a cancer stem cell marker in brain tumors? Cancer Treat Rev (2009) 35:403-8. doi:10.1016/j.ctrv.2009.03.002.
25. He H, Li MW, Niu CS. The pathological characteristics of glioma stem cell niches. J Clin Neurosci (2012) 19:121-7. doi:10.1016/j.jocn.2012.01.007.
26. Yan X, Ma L, Yi D, Yoon JG, Diercks A, Foltz G, et al. A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations. Proc Natl Acad Sci U S A (2011) 108(4):1591-6. doi:10.1073/pnas.1018696108.
27. Tomuleasa C, Soritau O, Rus-Ciuca D, Ioani H, Susman S, Petrescu M, et al. Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells. J BUON (2010) 15(3):583-91.
28. Brescia P, Richichi C, Pelicci G. Current strategies for identification of glioma stem cells: adequate or unsatisfactory? J Oncol (2012) 2012:376894. doi:10.1155/2012/376894.
29. Choy W, Nagasawa DT, Trang A, Thill K, Spasic M, Yang I. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme. Neurosurg Clin N Am (2012) 23:391-405. doi:10.1016/j.nec.2012.04.011.
30. Sun Y, Pollard S, Conti L, Toselli M, Biella G, Parkin G, et al. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci (2008) 38(2):245-58. doi:10.1016/j.mcn.2008.02.014.
31. Motegi H, Kamoshima Y, Terasaka S, Kobayashi H, Houkin K. A novel adherent culture method of glioblastoma cells expressing CD133 using collagen-1-coated plates. Hokkaido Igaku Zasshi (2012) 87(4-5):147-51.
32. Wang P, Mao Q, Wang X, Chen MN, Gan LA, Liu YH. Adherent culture of CD133+ cells in glioblastomas and expression of ADLH1. Sichuan Da Xue Xue Bao Yi Xue Ban (2011). 42(3):413-6.
33. Guo Y, Liu S, Wang P. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology (2011) 59(4):763-75. doi:10.1111/j.1365-2559.2011.03993.x.
34. He J, Liu Y, Zhu T, Zhu J, Dimeco F, Vescovi AL, et al. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. Mol Cell Proteomics (2012). 11(6):M111.010744. doi:10.1074/mcp.M111.010744.
35. Donnenberg VS, Donnenberg AD, Zimmerlin L, Landreneau RJ, Bhargava R, Wetzel RA, Basse P, Brufsky AM. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Cytometry B Clin Cytom (2010). 78(5):287-301. doi:10.1002/cyto.b.20530.
36. Ishiwata T, Teduka K, Yamamoto T, Kawahara K, Matsuda Y, Naito Z. Neuroepithelial stem cell marker Nestin regulates the migration, invasion and growth of human gliomas. Oncol Rep (2011) 26(1):91-9. doi:10.3892/or.2011.1267.
37. Jin X, Jin X, Jung JE, Beck S, Kim H. Cell surface Nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun (2013) 433:496-501. doi:10.1016/j.bbrc.2013.03.021.